[1]胡志良.冠状动脉粥样硬化性心脏病患者血浆溶血磷脂酸及脂蛋白相关磷脂酶A2水平检测的临床意义[J].新乡医学院学报,2018,35(12):1097-1100.[doi:10.7683/xxyxyxb.2018.12.013]
　HU Zhi-liang.Clinical significance of plasma lysophosphatidic acid and lipoprotein associated phospholipase A2 levels in patients with coronary atherosclerotic heart disease[J].Journal of Xinxiang Medical University,2018,35(12):1097-1100.[doi:10.7683/xxyxyxb.2018.12.013]
点击复制

冠状动脉粥样硬化性心脏病患者血浆溶血磷脂酸及脂蛋白相关磷脂酶A2水平检测的临床意义
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
35
期数:
2018年12
页码:
1097-1100
栏目:
临床研究
出版日期:
2018-12-05

文章信息/Info

Title:
Clinical significance of plasma lysophosphatidic acid and lipoprotein associated phospholipase A2 levels in patients with coronary atherosclerotic heart disease
作者:
胡志良
（驻马店市中心医院心血管内三科，河南　驻马店　463000）
Author(s):
HU Zhi-liang
（Department of NO.3 Cardiology，the Central Hospital of Zhumadian City，Zhumadian 463000，Henan Province，China）
关键词:
冠状动脉粥样硬化性心脏病; 血浆溶血磷脂酸; 脂蛋白相关磷脂酶A2; 病变程度
Keywords:
coronary atherosclerotic heart disease; lysophosphatidic acid; lipoprotein associated phospholipase acid A2; lesion degree
分类号:
R541.4
DOI:
10.7683/xxyxyxb.2018.12.013
文献标志码:
A
摘要:
目的　探讨血浆溶血磷脂酸（LPA）及脂蛋白相关磷脂酶A2（LP-PLA2）水平在评价冠状动脉粥样硬化性心脏病（CHD）患者冠状动脉病变程度中的临床意义。方法　选择2015年7月至2017年7月驻马店市中心医院收治的238例CHD患者为研究对象。根据临床症状及检查结果分为CHD组（n=186）和非CHD组（n=52）；将CHD组患者根据病情程度分为稳定型心绞痛组（n=82）、不稳定型心绞痛组（n=63）及急性心肌梗死组（n=41），根据冠状动脉造影结果将CHD组患者分为单支病变组（n=88）、双支病变组（n=60）及3支或以上病变组（n=38）。酶联免疫吸附试验测定各组患者血浆LPA和LP-PLA2水平，分析血浆LPA和LP-PLA2水平与冠状动脉病变程度的相关性。结果　急性心肌梗死组、不稳定型心绞痛组和稳定型心绞痛组患者血浆LPA、LP-PLA2水平及Gensini评分显著高于非CHD组（P<0.05），急性心肌梗死组和不稳定型心绞痛组患者血浆LPA、LP-PLA2水平及Gensini评分显著高于稳定型心绞痛组（P<0.05），急性心肌梗死组患者血浆LPA、LP-PLA2水平及Gensini评分显著高于不稳定型心绞痛组（P<0.05）。血浆LPA、LP-PLA2水平与Gensini评分呈显著正相关（r=0.577、0.609，P<0.05）。单支病变组、双支病变组和3支或以上病变组患者血浆LPA、LP-PLA2水平显著高于非CHD组（P<0.05），双支病变组和3支或以上病变组患者血浆LPA、LP-PLA2水平显著高于单支病变组（P<0.05），3支或以上病变组患者血浆LPA、LP-PLA2水平显著高于双支病变组（P<0.05）。结论　血浆LPA和LP-PLA2水平能够有效评估CHD的严重程度，并能够用于评估冠状动脉病变的进展。
Abstract:
Objective　To evaluate the clinical significance of plasma lysophosphatidic acid （LPA） and lipoprotein associated phospholipase acid A2 （LP-PLA2） levels in patients with coronary atherosclerotic heart disease(CHD).Methods　A total of 238 patients who were suspected coronary atherosclerotic heart disease in the Central Hospital of Zhumadian City from July 2015 to July 2017 were selected as the subjects.According to the clinical symptoms and examination results，the patients were divided into CHD group （n=186） and non-CHD group （n=52）.The patients in the CHD group were divided into stable angina group（n=82），unstable angina group （n=63） and acute myocardial infarction group （n=41） according to the disease degree，and according to the coronary angiography results they were divided into single lesion group （n=88），the double branch lesion group （n=60） and three or more lesions group （n=38）.Plasma LPA and LP-PLA2 levels were measured by enzyme-linked immunosorbent assay，and the correlation between plasma LPA and LP-PLA2 and severity of coronary artery disease was analyzed.Results　The levels of plasma LPA，LP-PLA2 and Gensini scores in the acute myocardial infarction group，unstable angina group and stable angina group were significantly higher than those in the non-CHD group（P<0.05）.The levels of plasma LPA，LP-PLA2 and Gensini scores in acute angina pectoris group and unstable angina group were significantly higher than those in stable angina group （P<0.05）.The levels of plasma LPA，LP-PLA2 and Gensini scores in the acute myocardial infarction group were significantly higher than those in the unstable angina group （P<0.05）.Pearson correlation analysis showed that plasma LPA and LP-PLA2 levels were positively correlated with Gensini score （r=0.577，0.609，P<0.05）.The levels of plasma LPA and LP-PLA2 in the single vessel disease group，double branch lesion group and three or more lesions group were significantly higher than those in the non-CHD group （P<0.05）.The levels of plasma LPA and LP-PLA2 in double branch lesion group and three or more lesions group were significantly higher than those in single lesion group （P<0.05）.The levels of plasma LPA and LP-PLA2 in three or more lesions group were significantly higher than those in double branch lesion group （P<0.05）.Conclusion　LPA and LP-PLA2 levels can effectively assess the severity of coronary heart disease and can be used to evaluate the progression of CHD.

参考文献/References:

［1］　刘超.血栓通注射液对冠状动脉粥样硬化性心脏病患者血流变学及血小板活化功能的影响［J］.世界中医药，2018，13（3）：672-675.
［2］　KURANO M，SUZUKI A，INOUE A，et al.Possible involvement of minor lysophospholipids in the increase in plasma lysophosphatidic acid in acute coronary syndrome［J］.Arterioscler Thromb Vasc Biol，2015，35（2）：463-470.
［3］　UESHIMA H，KADOWAKI T，HISAMATSU T，et al.Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population［J］.Atherosclerosis，2016，246（1）：141-147.
［4］　LI D，ZHAO L，YU J，et al.Lipoprotein-associated phospholipase A2 in coronary heart disease：Review and meta-analysis［J］.Clin Chim Acta，2017，465（1）：22-29.
［5］　GOSMANOVA E O，MIKKELSEN M K，MOLNAR M Z，et al.Association of systolic blood pressure variability with mortality，coronary heart disease，stroke，and renal disease［J］.J Am Coll Cardiol，2016，68（13）：1375-1386.
［6］　李艳艳，曹加淮，耿学军，等.踝臂指数、脉搏波传导速度及血尿酸评估冠心病病变程度的价值［J］.江苏医药，2016，42（22）：2476-2478.
［7］　牛镜磊.新型炎症标志物在动脉粥样硬化中的研究进展［J］.中国循环杂志，2017，32（5）：516-517.
［8］　刘俊田.动脉粥样硬化发病的炎症机制的研究进展［J］.西安交通大学学报（医学版），2015，36（2）：141-152.
［9］　陆攀，宋佳希.miR-181在动脉粥样硬化相关血管炎症和免疫调节中的研究进展［J］.临床检验杂志，2017，35（2）：125-128.
［10］　ABDEL-LATIF A，HERON P M，MORRIS A J，et al.Lysophospholipids in coronary artery and chronic ischemic heart disease［J］.Curr Opin Lipidol，2015，26（5）：432-437.
［11］　TRITAKIS V，TZORTZIS S，IKONOMIDIS I，et al.Association of arterial stiffness with coronary flow reserve in revascularized coronary artery disease patients［J］.World J Cardiol，2016，8（2）：231-239.
［12］　POKHAREL Y，SUN W，POLFUS L M，et al.Lipoprotein associated phospholipase A2 activity，apolipoprotein C3 loss-of-function variants and cardiovascular disease：the atherosclerosis risk in communities study［J］.Atherosclerosis，2015，241（2）：641-648.
［13］　WIRTWEIN M，MELANDER O，SJGREN M，et al.Elevated ambulatory systolic-diastolic pressure regression index is genetically determined in hypertensive patients with coronary heart disease［J］.Blood Press，2017，26（3）：174-180.
［14］　NOU E，LU M T，LOOBY S E，et al.Serum oxidized low-density lipoprotein decreases in response to statin therapy and relates independently to reductions in coronary plaque in patients with HIV［J］.AIDS，2016，30（4）：583-590.
［15］　李玉妹，张谨超，刘彦玲，等.血浆 LPA、Hcy联合检测在下肢深静脉血栓早期诊断中初步研究［J］.中国实验诊断学，2015，19（12）：2045-2048.
［16］　BOSTAN M，UYDU H A，YILDIRMIS S，et al.Pleiotropic effects of HDL subfractions and HDL-associated enzymes on protection against coronary artery disease［J］.Acta Cardiol，2015，70（3）：333-340.

相似文献/References:

[1]吕风华,张素荣,张跃光,等.冠状动脉粥样硬化性心脏病合并充血性心力衰竭患者血浆脑钠肽水平的检测[J].新乡医学院学报,2007,24(06):581.
[2]廖燕.老年冠状动脉粥样硬化性心脏病患者心功能与肺动脉压和心电指标的关系[J].新乡医学院学报,2012,29(09):696.
[3]郭鹏,李继红.不同类型冠状动脉粥样硬化性心脏病患者血浆D-二聚体和纤维蛋白原水平变化[J].新乡医学院学报,2012,29(09):698.
[4]李永锋,许志强,韩 鹏,等.冠状动脉粥样硬化性心脏病合并阻塞性睡眠呼吸暂停低通气综合征的临床分析 [J].新乡医学院学报,2012,29(10):784.
[5]舒　毅,陈幼萍,曾春平,等. ２型糖尿病合并冠状动脉粥样硬化性心脏病患者下肢血管病变相关因素分析[J].新乡医学院学报,2015,32(08):785.
[6]杨亚明,赵国安,冯春瑜,等.冠状动脉粥样硬化性心脏病患者的血脂代谢机制及药物治疗研究进展[J].新乡医学院学报,2021,38(10):996.[doi:10.7683/xxyxyxb.2021.10.020]
[7]许明发,王帅飞,苏国宝,等.不同血运重建方式治疗冠状动脉粥样硬化性心脏病合并左心室功能不全的早期疗效比较[J].新乡医学院学报,2018,35(11):1018.[doi:10.7683/xxyxyxb.2018.11.018]
　XU Ming-fa,WANG Shuai-fei,SU Guo-bao,et al.Comparison of early outcomes of two kinds of revascularization on the patients with coronary heart disease complicated with left ventricular dysfunction[J].Journal of Xinxiang Medical University,2018,35(12):1018.[doi:10.7683/xxyxyxb.2018.11.018]
[8]欧红萍,李 彬,周凤勤.颈动脉超声检查联合血清超敏C 反应蛋白水平检测在冠状动脉粥样硬化性心脏病诊断中的应用[J].新乡医学院学报,2014,31(10):825.[doi:10.7683/xxyxyxb.2014.10.016]
[9]王　一.冠状动脉粥样硬化性心脏病合并二尖瓣疾病和心房颤动患者同期行冠状动脉搭桥联合二尖瓣置换术和双极射频消融术疗效观察[J].新乡医学院学报,2019,36(2):155.[doi:10.7683/xxyxyxb.2019.02.013]
　WANG Yi.Clinical effect of coronary artery bypass grafting and mitral valve replacement and bipolar radiofrequency ablation on the patients with coronary atherosclerotic heart disease combined with mitral valve disease and atrial fibrillation[J].Journal of Xinxiang Medical University,2019,36(12):155.[doi:10.7683/xxyxyxb.2019.02.013]
[10]王　超,袁　宇.冠状动脉粥样硬化性心脏病患者肠道菌群丰度与血脂和血尿酸水平的相关性[J].新乡医学院学报,2019,36(7):623.[doi:10.7683/xxyxyxb.2019.07.006]
　WANG Chao,YUAN Yu.Correlation between gut flora abundance and blood lipid,blood uric acid levels in patients with coronary atherosclerotic heart disease[J].Journal of Xinxiang Medical University,2019,36(12):623.[doi:10.7683/xxyxyxb.2019.07.006]

更新日期/Last Update: 2018-12-05